Malaria Infections and Infestations Malaria
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Mothers with children 10 years or less who have febrile illness presumed to be malaria 2. Willingness of mothers to allow their child remain in study for a period of 14 days 3. Mothers who consent to their child having finger prick to collect blood for blood smears
Exclusion criteria
Exclusion criteria: 1. Child with severe illness or requiring parenteral medication 2. Child with other diseases, co-morbid with febrile illness Withdrawal Criteria: 1. Parents of children choosing not to continue with the study 2. Progression of illness in child
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The mothers/caregivers were asked about the treatment given to the child during visits by the research assistants. The mothers/caregivers were asked to record these details in their diary, which was checked on Day 7 from recruitment at the time of collecting Day 7 blood sample for microscopy examination. These data were used to assess the following: 1. Correct use of chloroquine, measured in terms of dose, frequency and duration 2. Timeliness of commencing treatment (commencing treatment within 24 hours of noticing fever in child) 3. Treatment outcome, measured by mean parasite clearance time, fever clearance time, and progression of illness as reported by mothers/caregivers 4. Use of the protocol. Proportion of mothers who referred to the treatment protocol in the treatment of last episode of malaria in children | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Attack rate of malaria over a period of one year 2. Sensitivity and specificity of presumptive diagnosis of malaria by mothers/caregivers | — |
Countries
Nigeria